Posts Tagged 'amarin pharma'

Bristol-Myers Squibb Settles Off-Label Marketing Suit

abilify maker settles off-label marketing lawsuitOne of the least-known facts in medicine is the amount of leeway a doctor has when it comes to prescribing medicine. They are essentially on their own; the final authority in determining the drugs their patients will take while under their care. So, while the FDA may have approved a drug to treat X condition, biology dictates that it might also have a positive effect on Y condition, and your ...

continue reading...

Amarin Wins Right to Promote Drug for Off-Label Use

In a post from late June of this year, we brought you the story of Amarin Pharmaceuticals – the company arguing for the ability to promote a drug for off-label use. Their case was based on a premise that, at the time, seemed, or so we thought, far-fetched: the FDA, in carrying out its regulatory duties and keeping the public safe from harm, was violating the company’s First Amendment right to free speech.

The company ...

continue reading...

Getting Sued for Doing Your Job: Amarin Pharma and the FDA

amarin pharma claims that the fda has violated its first amendment right to free speechThe job of a regulatory agency is to define, for those under its regulation, what is permissible behavior and what is not. It is tasked with laying down the ground rules: corporations can play on its field but they have to play by its rules. If they don’t, they get fined or they lose their right to play.

Regulation is a part ...

continue reading...